Sanofi Pasteur, TIV + H1N1, Pediatric Population
Condition: InfluenzaInterventions: Biological: Trivalent Inactivated Influenza Vaccine; Biological: Inactivated H1N1 VaccineSponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified December 2010
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | H1N1 | Infectious Diseases | Influenza | Influenza Vaccine | Pediatrics | Research | Swine Flu (H1N1) Vaccine | Vaccines